Dr. Kelsey and the Thalidomide Crisis

This chapter examines Dr. Frances Kelsey's crucial role in the FDA's refusal to approve thalidomide, emphasizing the need for thorough scientific evaluation after alarming reports linked the drug to severe birth defects. It also explores the subsequent regulatory reforms that arose from this tragedy, shaping modern drug approval processes to enhance public safety.